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Aims Current conventional ablation strategies for ventricular tachycardia (VT) aim to interrupt reentrant circuits by creating
ablation lesions. However, the critical components of reentrant VT circuits may be located at deep intramural sites.
We hypothesized that bipolar ablations would create deeper lesions than unipolar ablation in human hearts.
Methods
and results
Ablation was performed on nine explanted human hearts at the time of transplantation. Following explant, the hearts
were perfused by using a Langendorff perfusion setup. For bipolar ablation, the endocardial catheter was connected
to the generator as the active electrode and the epicardial catheter as the return electrode. Unipolar ablation was per-
formed at 50 Wwith irrigation of 25 mL/min, with temperature limit of 508C. Bipolar ablation was performed with the
same settings. Subsequently, in a patient with an incessant septal VT, catheterswere positioned on the septum fromboth
the ventricles and radiofrequency was delivered with 40 W. In the explanted hearts, there were a total of nine unipolar
ablations and fourbipolar ablations.The lesiondepthwas greaterwithbipolar ablation, 14.8 vs. 6.1 mm(P, 0.01), but the
width was not different (9.8 vs. 7.8 mm). All bipolar lesions achieved transmurality in contrast to the unipolar ablations.
In the patient with a septal focus, bipolar ablation resulted in termination of VT with no inducible VTs.
Conclusion By using a bipolar ablation technique, we have demonstrated the creation of significantly deeper lesions without increas-
ing the lesion width, compared with standard ablation. Further clinical trials are warranted to detail the risks of this
technique.
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Background
Catheter ablationof post-infarction ventricular tachycardia (VT) relies
on the interruption of one or more critical reentry circuits, most fre-
quently by radiofrequency (RF) ablation. Irrigated RF catheter ablation
has allowed for greater power delivery without coagulum formation
and increased lesion depth.1 However, procedural failure to eliminate
all inducibleVT, aswell as recurrentVTafterRFablationcontinue tobe
a significant limitation and obstacle to the advancement of this
therapy.2,3 Ventricular tachycardia involving the interventricular
septum (IVS) is relatively frequent inpost-infarctionmyocardial ischae-
mia4aswell as innon-ischaemicdilatedcardiomyopathy.5Tachycardias
involving the IVS have special anatomical considerations, including dual
blood supply (left anterior descending branch of the left coronary
artery and right coronary artery), the location of the conduction
system, and the possibility of true mid-myocardial septal scars. This
combination of factors may influence the outcome of ablation and
may account for a significant number of ablation failures and recur-
rences. For example, the risk of damaging the conduction system
may impose constraints on the delivery of therapy for someVTorigin-
ating fromthe IVS. Furthermore, the inability to create truly transmural
lesions across the IVS (hence not reaching critical intramural areas),
even with the use of irrigated catheters, has been identified as a
cause of ablation failure.4–7 Sivagangabalan et al.,8 using a chronic
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ovine infarctmodel, havepreviously demonstrated that septalVTs typ-
ically have a common intramural isthmus capable of exit on either side
of the septum, and ablation was frequently necessary on both sides of
the septum to render the tachycardia non-inducible.
Experimentalmodelshavedemonstrated that IVS lesion transmur-
ality can be achievedmore readily with dual catheter bipolar ablation
than with sequential unipolar ablation.9,10 Despite the success of
bipolar ablation both in vitro and in vivo animal studies, there has
been limiteddemonstrationof its application inhumans.11 In addition,
there has been limited clinical evaluation of the morphology and
depth of the lesions in human hearts. In the clinical setting, it would
be expected that the septal substrate involved various degrees of
fibrosis and hypertrophy, not encountered in the animal studies,
thus, it is crucial to demonstrate lesion depth in hearts with cardiac
disease that would be the targets for this technique. Thus, we evalu-
atedwhether transmural ablation lesions could be createdwith a two
catheter bipolar ablation configuration inhypertrophied andfibrosed
human hearts ex vivo in a human Langendorff model.We sequentially
translated this expertise to a case of a patient with previous failed
standard single catheter ablation for a septal VT; this was successfully
targeted with bipolar ablation.
Methods
In vitro experiments
The experimental protocol was approved by the University Health
Network ethics committee and the informed consent was obtained
from each patient. Nine human hearts were obtained at the time of
cardiac transplantation. Followingexplant, the coronary arterieswere se-
lectively cannulated and the hearts perfused by using a modified Langen-
dorff perfusion setup. The hearts were placed in circulating Tyrode’s
solution tomimic chamber blood flowandwere paced byepicardial elec-
trodes at a cycle length (CL) of 800 ms. Unipolar and bipolar ablationwas
performed at the basal left ventricular (LV) free wall at sites of maximal
thickness. Catheters were aligned endocardially and epicardially. The
endocardial catheter was connected to the RF generator as the active
electrode with the epicardial catheter as the return electrode.
A custom switch box allowed measurement from the distal thermo-
couple from each catheter, allowing the temperatures from the tip of
both catheters, as well as bipolar impedance and power to be logged
for each ablation. Both catheterswere positioned parallel to themyocar-
dium and stabilized by a single operator. Irrigated (25 mL/min) bipolar
ablation was performed at 50 W with temperature control from both
LV and right ventricular (RV) catheters, power limiting if either tempera-
ture exceeded 508C. The unipolar ablations were performed in a similar
manner, except the return electrode was an indifferent electrode. The
power and temperature control settings were identical. Each ablation
was performed for 60 s. A bipolar ablation was performed on each of
the four hearts assigned to the bipolar ablation, whereas a total of nine
unipolar ablations were performed on the five hearts assigned to the
unipolar group.
Statistical analysis
Values are presented as means+ standard deviation, except for ablation
parameters; temperature, power, and impedance are presentedwith the
range. Themaximal lesion depth andwidth was estimated for each lesion
by direct measurements on the tissue (Figure 1). An independent sample
t-test was used for comparison between the unipolar and the bipolar
ablation groups. A P, 0.05 was considered statistically significant.
Results
In vitro study results
In the explanted hearts, there were a total of nine unipolar ablations
and four bipolar ablations. The lesion depth was greater with bipolar
What’s new?
† First study of the lesion morphology during human bipolar
ablation.
† Bipolar radiofrequency ablation lesions in human myopathic
hearts are deeper, but not wider than standard unipolar
lesions.
† Bipolar ablation may be suited for deep intra-myocardial
circuits, not accessible with unipolar ablation.
† Bipolar ablation may be an essential part of the toolkit for
ablation of septal and mid-myocardial ventricular tachycardia
circuits.
Figure 1 (A) An example of two unipolar ablation lesions can be
clearly seen on the epicardial surface (arrows). (B) A cylinder con-
taining a bipolar ablation lesion has been cut out to demonstrate the
transmural nature of the lesion. For comparison, (C) shows a not
quite transmural lesion from a unipolar ablation in a thinner
portion of myocardium. The lesion has been circled with a dotted
line for clarity.
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ablation, 14.8+0.5 vs. 6.1+ 1.7 mm (P, 0.01), but the width was
not different (9.8+ 1.9 vs. 7.8+3.4 mm, P ¼ ns). All bipolar
lesions achieved transmurality in contrast to the unipolar ablations
(Figure 1). For the bipolar ablations, the average temperature of the
active catheter was 418C (37–468C) and the temperature of the
return catheter electrode was 408C (37–498C). The average
powerwas 41 W (36–45 W) and the impedance 97 V (81–115 V).
Clinical case presentation and procedural
details
The patient is a 56-year-old male with ischaemic cardiomyopathy in
the setting of peripheral vascular disease, hypertension, hyperlipid-
aemia, and hypothyroidism.
His medical history was significant for myocardial infarction in
1989with subsequent bypass surgery in 1990.Aprophylactic implan-
table cardioverter-defibrillator (ICD)was implanted in 2002.His first
presentation with ventricular arrhythmia was in November 2009
when he presented with two appropriate shocks for ventricular fib-
rillation, and then another shock forVT in2010. In July 2011, hedevel-
oped increasing angina, and underwent coronary angiography which
was complicated by VT and another ICD discharge, despite treat-
ment with mexiletine and amiodarone. The patient was not
deemed suitable for revascularization. The possibility of performing
ethanol ablation was abandoned due to the poor LV function and
unsuitable anatomy.
There were two clinical tachycardia morphologies, both with left
bundle branch block morphology. Due to the extensive coronary
artery disease, the arrhythmia was poorly tolerated.
Ventricular tachycardia ablation was attempted initially in August
2011. During the electrophysiological (EP) study, four VTs with CL
of 269–446 ms were readily induced. Activation mapping of the LV
endocardium during the slowest VTmorphology revealed an exten-
sive area of mid-diastolic and pre-systolic potentials in addition to
fractionated electrocardiograms between the mitral annulus and
the inferiorwall close to the IVS.Concealedentrainmentwasdemon-
strated in this region, with long stimulus to QRS intervals, suggestive
of an entry site. After several ablations were performed from both
sides of the IVS, the patient was still inducible in tachycardia and
the procedure was abandoned. During the following 3 months, the
patient presented with frequent episodes of tachycardia necessitat-
ing antitachycardia pacing and defibrillation from the device.
However, as the rate was substantially slower, the device frequently
did not detect the arrhythmia. Despite the slower rate, the patient
experienced angina and hypotension during VT.
The patient was taken to the EP lab for a second procedurewhile in
incessant slow VT. Activation mapping of the stable VT from the RV
endocardium revealed signals that preceded the surfaceQRS electro-
cardiograms by as much as 48 ms, with concealed entrainment with
optimal post-pacing intervals. Multiple ablations in the RV IVS resulted
only in slowing in the CL to 682 ms, but not termination. At this point,
the decision was made to attempt overdrive suppression in atrial
demandmode (AAI), by using his ICD. Thiswas successful, with a con-
ductedQRSwidthof 95 ms.Unfortunately, theVTaccelerated toover
90 per minute, requiring aggressive pace termination.
Because of intolerable symptoms, presumably due to ischaemia,
the haemodynamic alteration associated with this slow VT, and the
loss of atrioventricular synchrony, the patient was brought back
2weeks later for a third ablation. This was planned a priori as a biven-
tricular endocardial ablation. Prior to the procedure, the thickness of
the IVS was measured at 11 mm by an echocardiogram. Ventricular
tachycardia with a CL of 684 ms was induced with programmed ven-
tricular stimulation and the morphology was identical to the one left
during the previous procedure. Two ablation catheters (St Jude IBI
Cool-Path Irrigated) were positioned on both sides of the IVS
(Figure 2) and the post-pacing intervals following entrainment were
optimal from both LV and RV septal endocardium. The RV signals
preceded the left-sided signals by 40 ms (Figure 3). Ablation was
initiated at 20 W and titrated up to 40 W, with a temperature limit
of 658C and the flow rate was maintained at 30 cc/min during abla-
tion. The VT terminated when the power was increased to 40 W,
during the fifth RF application (Figure 3). A total of nine bipolar abla-
tion lesions were delivered across the septum. The clinical VT could
not be re-induced during programmed stimulation after the ablation.
However, a much faster and haemodynamically unstable VT (CL ¼
337 ms) was induced, but not targeted for ablation, hence no
further ablation was performed. The patient had some recurrences
of VT during the first months after ablation, but at 1-year follow-up
he is without symptomatic or sustained arrhythmias and is currently
doing well on the same antiarrhythmic medications as pre-ablation
(amiodarone and mexiletine).
Discussion
In diseased human hearts that often have thickened ventricular myo-
cardium,we have demonstrated here, that a single RF generator, two
catheter bipolar ablation technique is feasible and produces greater
lesion depth than standard unipolar ablation. Most importantly, this
is the initial pathological description in humans that transmural abla-
tion lesions can be achieved across areas of thick and scarred myo-
cardium with a two catheter, single RF generator bipolar ablation.
Such a strategy warrants consideration as it presents an option for
greater lesion depth by using currently existing technology available
to electrophysiologists.
LV abl LV abl
RV abl RV abl
LAO 45° RAO 30°
Figure2 Fluoroscopic imageof the catheter setup in left anterior
oblique 458 and right anterior oblique 308 projections which shows
the close approximation of the ablation catheters on the intraven-
tricular septum. RV abl, right ventricular ablation catheter; LV abl,
left ventricular ablation catheter; LAO, left anterior oblique;
RAO, right anterior oblique.
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One important limitationofVTablation is thedepthofpenetration
of the lesions. Even though improvedby theuseof irrigatedcatheters,
this remains a challenge in scarred and hypertrophied hearts with
intramural and critical mid-myocardial or epicardial circuits.
Although epicardial ablation has been useful in the treatment of
truly epicardial circuits, deep intramural circuits have proven to be
difficult targets.5
Traditionally, RF ablation current is deployed in a unipolar fashion
between the tip of the mapping/ablation catheter and an indifferent
electrodeplacedon thepatient surface (oftenon the thigh). Recently,
multipolar catheters have been introduced that provide the possibil-
ity to ablate in a bipolar fashion between individual electrodes on a
single catheter.12–14 With two separate standard ablation catheters
inside the heart on either side of the target substrate (IVS or free
wall), it is possible to allow for the flow of the RF current between
the two intracardiac electrodes. Recently, Koruth et al.11 presented
their initial experience from nine patients, including four patients
with septal VTs. Their result were promising, as they could success-
fully ablate five of six VTs; however, there were some late recur-
rences in their case series.
Sivagangabalan et al., using a chronic ovine infarct model, showed
that septal VTs typically have a common intramural isthmus
capable of exit on either side of the septum with a very short delay
between the earliest LV and RV activations. In that study, septal RF
energy was delivered in the ventricle with the earliest tachycardia
breakout. Failure to create a transmural septal ablation lesion at the
scar border resulted in persistent inducibility of septal VT and
shifted the earlier activation to the opposite ventricle, while ablation
from both sides of the septum resulted in transmural ablation that
rendered septal VT non-inducible. Further experimental work in
phantom agar models9 and porcine ventricular tissue11 has revealed
that bipolar ablation is not as sensitive to contact and catheter align-
ment as unipolar ablation. Thismay be an advantage of the bipolar ab-
lation technique in positioning catheters in beating human hearts in
the clinical setting andobtaining successful terminationof tachycardia
without the need for added expertise.
Various strategies have been attempted to deal with deep intra-
mural arrhythmia targets including ‘needle’ ablation and transcoron-
ary ethanol ablation. Both these techniqueswill require in addition to
adapting to new technology, training of catheter deployment.Needle
ablation involves a specially designed catheter for mapping and abla-
tion that is currently in development and trials. Sapp et al.15 described
pre-clinicalworkwith acatheter developed for intra-myocardial drug
delivery. They were able to produce very large and deep lesions with
this catheter in animalmodels. This technique has someprerequisites
such as catheter having to be directed perpendicular in order for the
needle to engage themyocardium and the catheter design that needs
to be verified in human experience.
Another alternative, especially for intramural septal VT is ethanol
ablation. This method has been employed in patients with some
success.6,7 This technique is largely limited by the complexity of the
procedure and the fact that the area of interest has to be nourished
by an accessible coronary artery branch that is of suitable size. The





















Figure 3 The electrocardiograms (EGMs) from the successful site during mapping. The right ventricular signal is much earlier (EGM-QRS ¼ 60
ms) than the left ventricular signals (EGM-QRS ¼ 20 ms), which is in line with the left bundle morphology of the tachycardia. Also note the intense
fractionation and low amplitude of the local EGMs. During ablation the tachycardia terminates after 16 s, when the power had been increased to
40 W.
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may be best suited as a last resort, especially in patients with very
poor LV function as was the case in our patient.
It is increasingly recognized that the successful ablation of septal
VT circuits may require RF application on both endocardial surfaces
of the IVS. Our study has demonstrated that IVS lesion transmurality
can be achievedmore readily with bipolar ablation thanwith unipolar
ablation. For patients with therapy-resistant ventricular arrhythmia,
bipolar ablationmay be an important part of a toolkit for the ablating
electrophysiologist.
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